1. That the Chief Executive Officer, GMCA & TfGM Decision Notice for the approval of loans to Manchester Science Partnerships Limited (“MSP”) and to IRAF UK Vantage 3 Limited (“Vantage”) be noted.
2. That authority be delegated to the Chief Executive Officer, GMCA & TfGM, and the GMCA Treasurer, in consultation with the Portfolio Lead for Investment and Resources, to approve projects for funding and agree urgent variations to the terms of funding in the period 13 February 2021 to 25 March 2021. Any recommendations that are approved under the delegation will be reported to the next available meeting of the GMCA.